516 related articles for article (PubMed ID: 12488956)
1. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
3. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD38 autoantibodies in type? diabetes.
Mallone R; Perin PC
Diabetes Metab Res Rev; 2006; 22(4):284-94. PubMed ID: 16544364
[TBL] [Abstract][Full Text] [Related]
5. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
[TBL] [Abstract][Full Text] [Related]
6. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
8. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
Sordi V; Lampasona V; Cainarca S; Bonifacio E
Diabet Med; 2005 Dec; 22(12):1770-3. PubMed ID: 16401328
[TBL] [Abstract][Full Text] [Related]
9. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
10. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
12. [Association of autoantibody and cytokines with latent autoimmune diabetes in adults].
He FP
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1323-5. PubMed ID: 14678903
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune markers in young Malaysian patients with type 1 diabetes mellitus.
Nazaimoon WM; Azmi KN; Rasat R; Ismail IS; Singaraveloo M; Mohamad WB; Letchuman R; Sheriff IH; Faridah I; Khalid BA
Med J Malaysia; 2000 Sep; 55(3):318-23. PubMed ID: 11200711
[TBL] [Abstract][Full Text] [Related]
14. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterization.
Mallone R; Ortolan E; Baj G; Funaro A; Giunti S; Lillaz E; Saccucci F; Cassader M; Cavallo-Perin P; Malavasi F
Diabetes; 2001 Apr; 50(4):752-62. PubMed ID: 11289039
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
17. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients].
Zhang C; Zhou ZG; Lin J; Huang G; Wang JP; Zhang DM; Zhou M; Yang XL
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):797-801. PubMed ID: 18756979
[TBL] [Abstract][Full Text] [Related]
18. CD38 autoimmunity: recent advances and relevance to human diabetes.
Antonelli A; Ferrannini E
J Endocrinol Invest; 2004; 27(7):695-707. PubMed ID: 15505998
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
